Past, Present, and Future of Wastewater-Based Epidemiology

Jul 10, 2023 | Denver, Colorado

GT Molecular joined the burgeoning wastewater-based epidemiology (WBE) field during the early days of the COVID-19 pandemic. The initial validated molecular workflow stemmed from a local collaboration between academia and industry that culminated in a validated service offering spanning 44 states within the Continental United States. While the initial service offering included SARS-CoV-2 and all associated controls, wastewater began gaining traction as a viable sample to monitor additional pathogens including mpox, influenza, and respiratory syncytial virus. Throughout the WBE expansion journey, we at GT Molecular learned how to quickly adapt workflows and assay development pipelines to accommodate various pathogens with unique features and characteristics.

During the presentation, Dr. Kane, GT Molecular' s Director of Research and Development, will outline various success stories resulting from wastewater data and will also discuss hard lessons learned during the expansion phase. The future of WBE from the direction and guidance of the CDC will also be explored. Ultimately, wastewater surveillance continues to proves a tractable and economic compliment to traditional, clinic-based epidemiology.

See schedule and more information about the NACCHO Conference!

Previous
Previous

Wastewater Pathogen Monitoring Yields Timely, Actionable Data

Next
Next

CDC collaborates with molecular diagnostics developer GT Molecular to create digital PCR assays as well as multiplex dPCR panels.